Double Medical Technology (002901.SZ) Stock Price

Double Medical Technology Price

SZSE·CLOSED
43.37CNY+0.17 (+0.39 %)
Market closed

Revenue has compounded at 21.7% per year over the past 10 years to 2.14 B CNY. Earnings per share have declined at 10.7% per year over the last 10 years. Double Medical Technology's net margin stands at 16.7%, down from 38.2% several years earlier. Double Medical Technology currently offers a dividend yield of about 0.58%. The payout ratio is around 29% of earnings. Analysts set a median price target of 45.53 CNY, implying 5.0% above the current price. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 9% above its 52-week low.

Double Medical Technology stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Double Medical Technology over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Double Medical Technology stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Double Medical Technology's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Double Medical Technology Stock Price History
DateDouble Medical Technology Price
8/5/202643.37 CNY
8/4/202643.20 CNY
8/3/202642.70 CNY
7/31/202643.75 CNY
7/30/202644.21 CNY
7/29/202644.21 CNY
7/28/202643.49 CNY
7/27/202644.43 CNY
7/24/202643.49 CNY
7/23/202643.41 CNY
7/22/202643.84 CNY
7/21/202644.33 CNY
7/20/202644.62 CNY
7/17/202646.32 CNY
7/16/202647.69 CNY
7/15/202648.23 CNY
7/14/202646.79 CNY
7/13/202645.45 CNY
7/10/202644.76 CNY
7/9/202644.97 CNY
7/8/202643.33 CNY
7/7/202644.13 CNY
7/6/202646.17 CNY
7/3/202645.48 CNY
7/2/202643.56 CNY
7/1/202642.77 CNY
6/30/202641.78 CNY
6/29/202643.09 CNY
6/26/202641.86 CNY
6/25/202642.02 CNY
6/24/202642.37 CNY
6/23/202642.05 CNY
6/22/202640.86 CNY
6/18/202642.21 CNY
6/17/202641.93 CNY
6/16/202641.89 CNY
6/15/202642.46 CNY
6/12/202642.15 CNY
6/11/202640.95 CNY
6/10/202641.64 CNY
6/9/202641.12 CNY
6/8/202640.15 CNY
6/5/202640.46 CNY
6/4/202639.89 CNY
6/3/202640.14 CNY
6/2/202640.78 CNY
6/1/202640.74 CNY
5/29/202640.38 CNY
5/28/202640.58 CNY
5/27/202641.50 CNY
5/26/202641.49 CNY
5/25/202640.94 CNY
5/22/202641.18 CNY
5/21/202641.54 CNY
5/20/202640.73 CNY
5/19/202640.46 CNY
5/18/202640.06 CNY
5/15/202640.44 CNY
5/14/202640.53 CNY
5/13/202641.00 CNY
5/12/202640.80 CNY
5/11/202642.01 CNY
5/8/202641.90 CNY
5/7/202643.17 CNY
5/6/202642.85 CNY
4/30/202643.40 CNY
4/29/202642.31 CNY
4/28/202641.73 CNY
4/27/202641.85 CNY
4/24/202642.02 CNY
4/23/202643.86 CNY
4/22/202644.56 CNY
4/21/202644.02 CNY
4/20/202643.98 CNY
4/17/202643.78 CNY
4/16/202644.12 CNY
4/15/202644.14 CNY
4/14/202644.66 CNY
4/13/202642.56 CNY
4/10/202643.34 CNY
4/9/202642.50 CNY
4/8/202644.06 CNY
4/7/202643.19 CNY
4/3/202643.05 CNY
4/2/202643.71 CNY
4/1/202645.00 CNY
3/31/202643.78 CNY
3/30/202643.61 CNY
3/27/202643.05 CNY
3/26/202642.00 CNY
3/25/202642.31 CNY
3/24/202641.85 CNY
3/23/202640.61 CNY
3/20/202642.65 CNY
3/19/202643.21 CNY
3/18/202644.30 CNY
3/17/202644.89 CNY
3/16/202645.03 CNY
3/13/202644.99 CNY
3/12/202644.54 CNY
3/11/202645.28 CNY
3/10/202645.30 CNY
3/9/202644.22 CNY
3/6/202645.55 CNY
3/5/202645.34 CNY
3/4/202645.40 CNY
3/3/202647.07 CNY
3/2/202647.87 CNY
2/27/202649.18 CNY
2/26/202648.50 CNY
2/25/202648.28 CNY
2/24/202648.12 CNY
2/13/202647.52 CNY
2/12/202647.87 CNY
2/11/202647.84 CNY
2/10/202648.63 CNY
2/9/202649.04 CNY
2/6/202649.71 CNY
2/5/202650.18 CNY
2/4/202649.34 CNY
2/3/202649.76 CNY
2/2/202649.20 CNY
1/30/202651.11 CNY
1/29/202650.96 CNY
1/28/202651.22 CNY
1/27/202651.90 CNY
1/26/202648.43 CNY
1/23/202650.13 CNY
1/21/202649.95 CNY
1/20/202649.28 CNY
1/19/202650.36 CNY
1/15/202650.86 CNY
1/14/202650.51 CNY
1/13/202652.20 CNY
1/12/202650.95 CNY
1/9/202651.19 CNY
1/8/202649.58 CNY
1/7/202649.48 CNY
1/6/202650.29 CNY
1/5/202649.64 CNY
12/31/202547.37 CNY
12/30/202548.03 CNY
12/29/202548.32 CNY
12/26/202549.14 CNY
12/25/202549.64 CNY
12/24/202549.34 CNY
12/23/202549.60 CNY
12/22/202549.56 CNY
12/19/202548.99 CNY
12/18/202548.83 CNY
12/17/202548.51 CNY
12/16/202549.10 CNY
12/15/202548.93 CNY
12/12/202547.55 CNY
12/11/202547.87 CNY
12/10/202548.11 CNY
12/9/202548.22 CNY
12/8/202548.46 CNY
12/5/202548.28 CNY
12/4/202548.25 CNY
12/3/202548.57 CNY
12/2/202548.94 CNY
12/1/202549.42 CNY
11/28/202548.18 CNY
11/27/202548.05 CNY
11/26/202547.79 CNY
11/25/202547.80 CNY
11/24/202547.30 CNY
11/21/202547.16 CNY
11/20/202548.31 CNY
11/19/202548.26 CNY
11/18/202548.64 CNY
11/17/202548.46 CNY
11/14/202550.03 CNY
11/13/202549.56 CNY
11/12/202549.70 CNY
11/11/202549.04 CNY
11/10/202549.24 CNY
11/7/202549.03 CNY
11/6/202549.57 CNY
11/5/202549.52 CNY
11/4/202550.12 CNY
11/3/202551.85 CNY
10/31/202550.04 CNY
10/30/202549.36 CNY
10/29/202553.18 CNY
10/28/202555.86 CNY
10/27/202553.41 CNY
10/24/202552.79 CNY
10/23/202551.94 CNY
10/22/202552.26 CNY
10/21/202552.19 CNY
10/20/202552.40 CNY
10/17/202551.85 CNY
10/16/202554.79 CNY
10/15/202555.52 CNY
10/14/202557.20 CNY
10/13/202559.00 CNY
10/10/202558.55 CNY
10/9/202558.15 CNY
9/30/202555.97 CNY
9/29/202553.43 CNY
9/26/202553.04 CNY
9/25/202555.50 CNY
9/24/202555.06 CNY
9/23/202552.44 CNY
9/22/202553.92 CNY
9/19/202554.00 CNY
9/18/202554.60 CNY
9/17/202554.66 CNY
9/16/202554.95 CNY
9/15/202554.66 CNY
9/12/202555.50 CNY
9/11/202555.84 CNY
9/10/202555.74 CNY
9/9/202555.72 CNY
9/8/202558.24 CNY
9/5/202554.32 CNY
9/4/202553.31 CNY
9/3/202554.44 CNY
9/2/202554.75 CNY
9/1/202555.78 CNY
8/29/202555.02 CNY
8/28/202554.26 CNY
8/27/202554.03 CNY
8/26/202557.86 CNY
8/25/202558.69 CNY
8/22/202558.41 CNY
8/21/202558.50 CNY
8/20/202558.72 CNY
8/19/202557.88 CNY
8/18/202559.71 CNY
8/15/202559.23 CNY
8/14/202557.32 CNY
8/13/202561.85 CNY
8/12/202562.68 CNY
8/11/202561.06 CNY
8/8/202558.78 CNY
Access this data via the Eulerpool API
Get Free API Key

Double Medical Technology Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
1.99 B CNY
793.50 M CNY
673.31 M CNY
Jan 1, 2022
1.43 B CNY
107.03 M CNY
92.56 M CNY
Jan 1, 2023
1.53 B CNY
64.93 M CNY
58.97 M CNY
Jan 1, 2024
2.14 B CNY
399.74 M CNY
356.80 M CNY
Jan 1, 2025 (e)
2.60 B CNY
434.24 M CNY
538.23 M CNY
Jan 1, 2026 (e)
3.00 B CNY
499.85 M CNY
691.41 M CNY
Jan 1, 2027 (e)
3.40 B CNY
567.53 M CNY
774.22 M CNY
Jan 1, 2028 (e)
3.81 B CNY
634.86 M CNY
844.60 M CNY

Double Medical Technology Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 4:25 PM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESM
201420152016201720182019202020212022202320242025e2026e2027e2028e
0.300.390.460.590.771.261.591.991.431.532.142.603.003.403.81
–31.2118.1628.5729.9762.8226.1725.73-28.086.9039.2721.9715.0913.5511.87
79.8780.5681.8282.6680.0585.2885.5084.0075.9464.6466.7466.7466.7466.7466.74
0.240.320.380.490.621.071.361.681.090.991.431.742.002.272.54
158.00211.00237.00348.00406.00536.00693.00793.00107.0064.00399.00434.00499.00567.00634.00
53.0253.9651.3058.5952.5942.6443.6939.777.464.1718.6916.6716.6516.6616.65
139.00188.00219.00295.00371.00465.00605.00673.0092.0058.00356.00538.00691.00774.00844.00
–35.2516.4934.7025.7625.3430.1111.24-86.33-36.96513.7951.1228.4412.019.04
––––0.400.500.600.800.50–0.250.500.500.50–
–––––25.0020.0033.33-37.50––100.00–––
51.90319.50360.00369.40400.10402.30402.20403.18420.71414.02414.02414.02414.02414.02414.02
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Double Medical Technology generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Double Medical Technology retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Double Medical Technology's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Double Medical Technology has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Double Medical Technology's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Double Medical Technology stock margins

The Double Medical Technology margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Double Medical Technology. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Double Medical Technology.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
85.46 %
43.73 %
38.17 %
Jan 1, 2021
84.00 %
39.79 %
33.76 %
Jan 1, 2022
75.97 %
7.46 %
6.45 %
Jan 1, 2023
64.68 %
4.24 %
3.85 %
Jan 1, 2024
66.75 %
18.72 %
16.71 %
Jan 1, 2025 (e)
66.75 %
16.67 %
20.67 %
Jan 1, 2026 (e)
66.75 %
16.67 %
23.06 %
Jan 1, 2027 (e)
66.75 %
16.67 %
22.74 %

Double Medical Technology Stock Revenue, EBIT, Earnings per Share

The Double Medical Technology earnings per share therefore indicates how much revenue Double Medical Technology has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
3.95 CNY
1.73 CNY
1.51 CNY
Jan 1, 2021
4.95 CNY
1.97 CNY
1.67 CNY
Jan 1, 2022
3.41 CNY
0.25 CNY
0.22 CNY
Jan 1, 2023
3.70 CNY
0.16 CNY
0.14 CNY
Jan 1, 2024
5.16 CNY
0.97 CNY
0.86 CNY
Jan 1, 2025 (e)
6.29 CNY
1.05 CNY
1.30 CNY
Jan 1, 2026 (e)
7.24 CNY
1.21 CNY
1.67 CNY
Jan 1, 2027 (e)
8.22 CNY
1.37 CNY
1.87 CNY

Double Medical Technology business model & stock analysis

Double Medical Technology Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Double Medical Technology historical P/E ratio, EBIT multiple, and P/S ratio

Double Medical Technology annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Double Medical Technology shares outstanding

The number of shares of Double Medical Technology was 414.02 M in 2025. This indicates how many shares Double Medical Technology is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
402.20 M Stocks
Jan 1, 2021
403.18 M Stocks
Jan 1, 2022
420.71 M Stocks
Jan 1, 2023
414.02 M Stocks
Jan 1, 2024
414.02 M Stocks
Jan 1, 2025 (e)
414.02 M Stocks
Jan 1, 2026 (e)
414.02 M Stocks
Jan 1, 2027 (e)
414.02 M Stocks

Double Medical Technology Dividend History

7 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.50CNY↑ 100.0%1×
May 30, 20250.50CNY↑ 100.0%1/1
20240.25CNY↓ 50.0%1×
20220.50CNY↓ 37.5%1×
20210.80CNY↑ 33.3%1×
20200.60CNY↑ 20.0%1×
20190.50CNY↑ 25.0%1×
20180.40CNY—1×

Double Medical Technology dividend history and estimates

In 2025, Double Medical Technology paid a dividend amounting to 0.50 CNY. Dividend means that Double Medical Technology distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2019
0.50 CNY
0.00 CNY
Jan 1, 2020
0.60 CNY
0.00 CNY
Jan 1, 2021
0.80 CNY
0.00 CNY
Jan 1, 2022
0.50 CNY
0.00 CNY
Jan 1, 2024
0.25 CNY
0.00 CNY
Jan 1, 2025
0.50 CNY
0.00 CNY
Jan 1, 2026 (e)
0.00 CNY
0.50 CNY
Jan 1, 2027 (e)
0.00 CNY
0.50 CNY

Double Medical Technology dividend payout ratio

In 2025, Double Medical Technology had a payout ratio of 38.46%. The payout ratio indicates the percentage of the company's profits that Double Medical Technology distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
39.74 %
Jan 1, 2021
47.90 %
Jan 1, 2022
227.27 %
Jan 1, 2023
101.40 %
Jan 1, 2024
29.01 %
Jan 1, 2025 (e)
38.46 %
Jan 1, 2026 (e)
29.94 %
Jan 1, 2027 (e)
26.74 %

Current Double Medical Technology forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
83.33 % (5)
Hold
16.67 % (1)
Sell
0.00 % (0)
12M Price Target
45.53
Last Price
43.28
Currency
CNY
12M Return Potential
5.21 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Double Medical Technology stock

30/100
2
Environment
20
Social
68
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Double Medical Technology shareholder structure

% Name
18.03247%
Dabo Medical International Investment Co., Ltd
Dabo Medical International Investment Co., Ltd
0.11138%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
0.07353%
State Street Investment Management (US)
State Street Investment Management (US)
0.01848%
VanEck Investments Ltd.
VanEck Investments Ltd.
0.01398%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.00568%
HSBC Global Asset Management (UK) Limited
HSBC Global Asset Management (UK) Limited

Double Medical Technology Beneficial Ownership Filings (SEC 13D/G)

Free Float
16.4%
Float Shares
-
Shares Outstanding
-

Double Medical Technology Executives and Management Board

10 members · avg. age 50 · 30 % women

DR

Mr. Dongyang Ruan (51)

Chief Administrative Officer

541,000.00 CNY

Management

DC

Ms. Danhe Chen (45)

Chief Financial Officer

525,900.00 CNY

Board of Directors

JL

Mr. Jiong Luo (57)

General Manager, Director · since 2011

1.32 M CNY
ZL

Mr. Zhixiong Lin (51)

Chairman of the Board · since 2004

598,800.00 CNY
ZL

Mr. Zhijun Lin (49)

Vice Chairman of the Board · since 2008

551,800.00 CNY
WX

Mr. Wei Xiao (59)

Independent Director

100,000.00 CNY
XH

Mr. Xiannan Hua (41)

Secretary of the Board

–
XL

Ms. Xiaoping Lin (46)

Director

–

Frequently asked questions about Double Medical Technology

Analysts currently set an average price target of 45.53 CNY for the Double Medical Technology stock (median: 45.53 CNY), implying +5.2 % versus the latest price. The consensus is based on 6 analyst ratings.

Double Medical Technology Analyst Price Targets 2026

6 analysts currently rate the Double Medical Technology stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Double Medical Technology to generate revenue of 3.00 B CNY and earnings per share of 1.67 CNY.

Double Medical Technology Analyst Price Targets 2026

Converted at the current exchange rate, the Double Medical Technology share trades at 5.56 EUR (43.37 CNY).

No history available for Double Medical Technology.

The expected revenue of Double Medical Technology is 3.00 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Double Medical Technology is 691.41 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Double Medical Technology is currently 25.97. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Double Medical Technology stock.

The price-to-sales ratio (P/S) of Double Medical Technology is currently 5.99. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Double Medical Technology stock.

The Eulerpool Quality Score for Double Medical Technology is 5/10.

The ISIN of Double Medical Technology is CNE1000032W7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Double Medical Technology is 002901.SZ. The ticker symbol is used to trade Double Medical Technology shares on the stock exchange.

Over the past 12 months, Double Medical Technology paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 0.58 %. For the coming 12 months, Double Medical Technology is expected to pay a dividend of 0.50 CNY.

The current dividend yield of Double Medical Technology is 0.58 %.

Double Medical Technology pays a dividend, distributed in the months of , , , .

Double Medical Technology paid dividends every year for the past 2 years.

For the upcoming 12 months, dividends amounting to 0.50 CNY are expected. This corresponds to a dividend yield of 1.15 %.

Double Medical Technology is assigned to the 'Health' sector.

To receive the latest dividend of Double Medical Technology from amounting to 0.5 CNY, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Double Medical Technology distributed 0.25 CNY as dividends.

The dividends of Double Medical Technology are distributed in CNY.

All fundamentals and in-depth analysis of Double Medical Technology

Our stock analysis for Double Medical Technology stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Double Medical Technology. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Double Medical Technology Stock
Double Medical Technology Revenue→
Double Medical Technology Stock
Double Medical Technology Net Income→
Double Medical Technology Stock
Double Medical Technology P/E→
Double Medical Technology Stock
Double Medical Technology P/S→
Double Medical Technology Stock
Double Medical Technology EBIT→
Double Medical Technology Stock
Double Medical Technology Dividend→
Double Medical Technology Stock
Double Medical Technology Directors Dealings→
Double Medical Technology Stock
Double Medical Technology Stocks→
Double Medical Technology Stock
Double Medical Technology Market capitalization→
Double Medical Technology Stock
Double Medical Technology Debt→
Double Medical Technology Stock
Double Medical Technology Liabilities→
Double Medical Technology Stock
Double Medical Technology Equity→
Double Medical Technology Stock
Double Medical Technology AAQS→
Double Medical Technology Stock
Double Medical Technology Employees→
Double Medical Technology Stock
Double Medical Technology ROE→
Double Medical Technology Stock
Double Medical Technology ROA→
Double Medical Technology Stock
Double Medical Technology ROCE→
Double Medical Technology Stock
Double Medical Technology News→
Double Medical Technology Stock
Double Medical Technology Analyst Price Targets→

Health Stocks

DoximityDosni Roha Indonesia Tbk PTDr Agarwal's Eye HospitaldorsaViDr Lalchandani LabsDongwha Pharm CoDr Reddy's LaboratoriesDongsung Pharmaceutical CoDr Soliman Abdel Kader Fakeeh Hospital Company SCJSCDongkook Pharmaceutical CoDr Sulaiman Al Habib Medical Services Group Company SJSCDongKoo Bio & Pharma CoAll Stocks A–Z →